Prasuna Velur, MD
Neurology · Los Angeles, CANPI 1992909592
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $875 of the $1,273 with a category attached, or 68.8%. Neuropace, Inc. accounts for 60.1% of it on its own, with 7 other manufacturers making up the rest. That places this record below the midpoint for neurology clinicians in CA, where the typical reported total is $885.
Across 11 payments — averaging $115.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuropace, Inc.$765
- Sanofi$113
- Argenx US, Inc.$103
- Amicus Therapeutics, Inc.$96
- Biocodex, Inc.$85
- Axsome Therapeutics, Inc.$48
- plus $64 from 2 others
What the payments were for
- Travel & lodging$39831%
- Food & beverage$87569%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuropace, Inc. | 3 | $765 |
| Sanofi | 1 | $113 |
| Argenx US, Inc. | 1 | $103 |
| Amicus Therapeutics, Inc. | 1 | $96 |
| Biocodex, Inc. | 1 | $85 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Jazz Pharmaceuticals Inc. | 1 | $46 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,273 in reported general payments places this provider in the 50th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Los Angeles
- Perry ShiehLos Angeles$2.4M
- David LiebeskindLos Angeles$1.9M
- John SternLos Angeles$999K
- Jeffrey CummingsLos Angeles$918K
- Alan RapoportLos Angeles$808K
- Alon AvidanLos Angeles$505K
- Mark LewLos Angeles$450K
- Dawn EliashivLos Angeles$364K
- Richard LewisLos Angeles$309K
- Margaret BurnettLos Angeles$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.